{"nct_id":"NCT03598608","title":"Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2018-10-17","start_date_type":"ACTUAL","primary_completion_date":"2026-01-16","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-16","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}